[PDF][PDF] Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction …

A Ielasi, B Cortese, A Varricchio, M Tespili… - …, 2015 - academia.edu
Aims: In this multicentre prospective registry we sought to evaluate the immediate and
midterm clinical outcomes following single or multiple overlapping bioresorbable vascular …

[PDF][PDF] Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

P Toušek, V Kočka, M Malý, M Kozel, R Petr… - …, 2016 - researchgate.net
Aims: Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-
elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing …

One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary …

P Widimsky, R Petr, P Tousek, M Maly… - Circulation …, 2015 - Am Heart Assoc
Background—Bioresorbable vascular scaffolds (BVS) represent promising new technology,
but data on their long-term outcomes in ST-segment–elevation myocardial infarction …

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'

V Kočka, M Malý, P Toušek, T Buděšínský… - European heart …, 2014 - academic.oup.com
Abstract Aims Bioresorbable vascular scaffolds (BVSs) have been studied in chronic
coronary artery disease, but not in acute ST-segment elevation myocardial infarction …

ST-Segment Elevation Myocardial Infarction–Ideal Scenario for Bioresorbable Vascular Scaffold Implantation?–

G Scalone, S Brugaletta, O Gómez-Monterrosas… - Circulation …, 2015 - jstage.jst.go.jp
Bioresorbable vascular scaffolds (BVS) represent a breakthrough technology for
percutaneous coronary intervention (PCI). In this context, because of the unique properties …

A 12–month angiographic and optical coherence tomography follow‐up after bioresorbable vascular scaffold implantation in patients with ST‐segment elevation …

J Kochman, M Tomaniak, Ł Kołtowski… - Catheterization and …, 2015 - Wiley Online Library
Objectives The aim of the study was to evaluate the healing process at 12 months after
ABSORB™ bioresorbable vascular scaffold (BVS) implantation in patients with ST‐segment …

Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish …

Ł Rzeszutko, Z Siudak, T Tokarek, K Plens… - … Cardiology/Postępy w …, 2016 - termedia.pl
Aim: To evaluate 12-month clinical outcome, safety and effectiveness of BVS implantation in
complex lesions and in stable angina (SA) or ACS. Material and methods: Five hundred …

Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold

J Wiebe, H Möllmann, A Most, O Dörr, K Weipert… - Clinical Research in …, 2014 - Springer
Objectives To evaluate safety and efficacy of the everolimus-eluting bioresorbable scaffold
(BVS) in patients with ST-segment elevation myocardial infarction (STEMI). Background …

Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study

R Diletti, A Karanasos, T Muramatsu… - European heart …, 2014 - academic.oup.com
Aims We evaluated the feasibility and the acute performance of the everolimus-eluting
bioresorbable vascular scaffolds (BVS) for the treatment of patients presenting with ST …

[HTML][HTML] Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)

T Kajiya, M Liang, RK Sharma… - …, 2013 - eurointervention.pcronline.com
Aims: Recent studies have demonstrated favourable clinical outcomes for the everolimus-
eluting bioresorbable vascular scaffold (BVS) ABSORB™ in patients with stable coronary …